Pharmacodynamics of cefepime alone and in combination with various antimicrobials against methicillin-resistant Staphylococcus aureus in an in vitro pharmacodynamic infection modelHUANG, Vanthida; RYBAK, Michael J.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 1, pp 302-308, issn 0066-4804, 7 p.Article

Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetationsCHA, Raymond; RYBAK, Michael J.Diagnostic microbiology and infectious disease. 2003, Vol 47, Num 3, pp 539-546, issn 0732-8893, 8 p.Article

Ceftobiprole : First Cephalosporin with Activity Against Methicillin-Resistant Staphylococcus aureusVIDAILLAC, Céline; RYBAK, Michael J.Pharmacotherapy. 2009, Vol 29, Num 5, pp 511-525, issn 0277-0008, 15 p.Article

Evaluation of daptomycin activity against Staphylococcus aureus in an in vitro pharmacodynamic model under normal and simulated impaired renal functionHUANG, Vanthida; RYBAK, Michael J.Journal of antimicrobial chemotherapy (Print). 2006, Vol 57, Num 1, pp 116-121, issn 0305-7453, 6 p.Article

Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic modelCHA, Raymond; RYBAK, Michael J.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 1, pp 259-262, issn 0305-7453, 4 p.Article

Linezolid and vancomycin, alone and in combination with rifampin, compared with moxifloxacin against a multidrug-resistant and a vancomycin-tolerant Streptococcus pneumoniae strain in an in vitro pharmacodynamic modelCHA, Raymond; RYBAK, Michael J.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 6, pp 1984-1987, issn 0066-4804, 4 p.Article

Pulsatile delivery of amoxicillin against Streptococcus pneumoniaeCHA, Raymond; RYBAK, Michael J.Journal of antimicrobial chemotherapy (Print). 2004, Vol 54, Num 6, pp 1067-1071, issn 0305-7453, 5 p.Article

Evaluation of Ceftaroline Activity versus Daptomycin (DAP) against DAP-Nonsusceptible Methicillin-Resistant Staphylococcus aureus Strains in an In Vitro Pharmacokinetic/Pharmacodynamic ModelSTEED, Molly; VIDAILLAC, Celine; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 7, pp 3522-3526, issn 0066-4804, 5 p.Article

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial VegetationsSTEED, Molly E; VIDAILLAC, Celine; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 12, pp 5187-5192, issn 0066-4804, 6 p.Article

Activity of oritavancin (LY333328), an investigational glycopeptide, compared to that of vancomycin against multidrug-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic modelCOYLE, Elizabeth A; RYBAK, Michael J.Antimicrobial agents and chemotherapy. 2001, Vol 45, Num 3, pp 706-709, issn 0066-4804Article

New milestones achieved in fluoroquinolone safetyTILLOTSON, Glenn S; RYBAK, Michael J.Pharmacotherapy. 2001, Vol 21, Num 3, pp 358-360, issn 0277-0008Conference Paper

Evaluation of vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus and heterogeneously vancomycin-intermediate S. aureus in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetationsLEONARD, Steven N; RYBAK, Michael J.Journal of antimicrobial chemotherapy (Print). 2009, Vol 63, Num 1, pp 155-160, issn 0305-7453, 6 p.Article

Short-course gentamicin in combination with daptomycin or vancomycin against Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsTSUJI, Brian T; RYBAK, Michael J.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 7, pp 2735-2745, issn 0066-4804, 11 p.Article

Influences of linezolid, penicillin, and clindamycin, alone and in combination, on streptococcal pyrogenic exotoxin A releaseCOYLE, Elizabeth A; CHA, Raymond; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1752-1755, issn 0066-4804, 4 p.Article

Bactericidal activities of daptomycin, quinupristin-dalfopristin, and linezolid against vancomycin-resistant Staphylococcus aureus in an in vitro pharmacodynamic model with simulated endocardial vegetationsCHA, Raymond; BROWN, William J; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 12, pp 3960-3963, issn 0066-4804, 4 p.Article

Effect of growth phase and pH on the in vitro activity of a new glycopeptide, oritavancin (LY333328), against Staphylococcus aureus and Enterococcus faeciumMERCIER, Renee-Claude; STUMPO, Carmine; RYBAK, Michael J et al.Journal of antimicrobial chemotherapy (Print). 2002, Vol 50, Num 1, pp 19-24, issn 0305-7453Article

Evaluation of Telavancin Activity versus Daptomycin and Vancomycin against Daptomycin-Nonsusceptible Staphylococcus aureus in an In Vitro Pharmacokinetic/Pharmacodynamic ModelSTEED, Molly E; VIDAILLAC, Céline; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 2, pp 955-959, issn 0066-4804, 5 p.Article

Activity of Telavancin against Staphylococcus aureus Strains with Various Vancomycin Susceptibilities in an In Vitro Pharmacokinetic/Pharmacodynamic Model with Simulated Endocardial VegetationsLEONARD, Steven N; VIDAILLAC, Céline; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 7, pp 2928-2933, issn 0066-4804, 6 p.Article

Pharmacodynamics : Relation to antimicrobial resistanceRYBAK, Michael J.American journal of infection control. 2006, Vol 34, Num 5, issn 0196-6553, S38-S45, SUP1Conference Paper

Daptomycin dose-effect relationship against resistant Gram-positive organismsCHA, Raymond; GRUCZ, Richard G; RYBAK, Michael J et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 5, pp 1598-1603, issn 0066-4804, 6 p.Article

Comparative Epidemiology of Bacteremia due to Methicillin-Resistant Staphylococcus aureus between Older and Younger Adults: A Propensity Score AnalysisKULLAR, Ravina; RYBAK, Michael J; KAYE, Keith S et al.Infection control and hospital epidemiology. 2013, Vol 34, Num 4, pp 400-406, issn 0899-823X, 7 p.Article

Tigecycline : First of a new class of antimicrobial agentsROSE, Warren E; RYBAK, Michael J.Pharmacotherapy. 2006, Vol 26, Num 8, pp 1099-1110, issn 0277-0008, 12 p.Article

Linezolid, levofloxacin, and vancomycin against vancomycin-tolerant and fluoroquinolone-resistant Streptococcus pneumoniae in an in vitro pharmacodynamic modelCHA, Raymond; AKINS, Ronda L; RYBAK, Michael J et al.Pharmacotherapy. 2003, Vol 23, Num 12, pp 1531-1537, issn 0277-0008, 7 p.Article

Emergence of methicillin-resistant Staphylococcus aureus with intermediate glycopeptide resistance: Clinical significance and treatment optionsRYBAK, Michael J; AKINS, Ronda L.Drugs (Basel). 2001, Vol 61, Num 1, pp 1-7, issn 0012-6667Article

Ceftaroline plus Avibactam Demonstrates Bactericidal Activity against Pathogenic Anaerobic Bacteria in a One-Compartment In Vitro Pharmacokinetic/Pharmacodynamic ModelWERTH, Brian J; RYBAK, Michael J.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 1, pp 559-562, issn 0066-4804, 4 p.Article